Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106188078B reveals a novel organocatalytic route for high-purity chiral spiro-oxindole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel method for (R)/(S)-6,6'-dihydroxy-5,5'-bisquinoline using CuCl2 oxidation and crystallization resolution, offering high purity and scalable production for pharma intermediates.
Novel asymmetric Mannich catalyst synthesis via eco-friendly oxygen oxidation. Delivers high ee values for beta-amino carbonyls. Reliable supply chain solution.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.
Novel oxaspiro diphosphine ligand synthesis enables >99% ee hydrogenation. Reliable supplier for high-purity chiral intermediates.
Novel iron-catalyzed asymmetric hydrogenation using chiral quinoline imidazoline ligands offers high enantioselectivity and cost-effective alternatives to noble metals for pharmaceutical intermediates.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Novel 9-step synthesis of (+) -Erogorgiaene using Pd catalysis. Reduces cost and improves scalability for pharmaceutical intermediates supply chains globally.
Patent CN101952242A details a novel convergent synthesis for renin inhibitors like aliskiren, offering improved stereocontrol and scalability for pharmaceutical manufacturers.
Patent CN110878104A reveals a safer two-step route for chiral phosphine ligands. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN116159601A reveals a novel eribulin intermediate route reducing chromium usage and boosting total yield to 33.7%, offering significant cost and supply chain advantages.
Patent CN115745823A details a novel asymmetric synthesis for high-purity chloramphenicol intermediates, offering cost reduction and scalable manufacturing solutions.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Patent CN105859800B details a high-yield synthesis of chiral ferrocene P,P ligands. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113582865A details a novel copper-catalyzed route for alpha,alpha-disubstituted chiral amino acid esters, offering high enantioselectivity and streamlined manufacturing for API intermediates.
Patent CN103319526A analysis reveals a novel organocatalytic route for P-chiral phenol derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.